Nutcracker Therapeutics: Funding, Investors & Team (Oct 2026)
Nutcracker Therapeutics is a biotech company that develops and produces mRNA therapeutics on its proprietary, microfluidic, and biochip-based platform. The company specializes in a fully-integrated system for the production of mRNA-therapeutics at the push of a button that enables scalable on-demand experimental and manufacturing capacity, thereby enabling healthcare companies to produce complex multimodal therapeutics at point of care. Nutcracker Therapeutics combines the productivity of RNA biology with innovations inspired by semiconductor manufacturing techniques to develop a proprietary miniaturized platform that enables the rapid discovery, development, and manufacturing of mRNA therapies and vaccines. Its ACORN platform is a first-of-its-kind, computer-controlled RNA manufacturing system that starts with a nucleic acid sequence of interest and produces optimized nanoparticle-encapsulated RNA therapeutics on dedicated, single-use biochips. Igor Khandros and Benjamin Eldridge established the company in Emeryville, California in 2018.
Nutcracker Therapeutics has raised $227M across 2 funding rounds on record, the most recent a Series C of $167M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nutcracker Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Nutcracker Therapeutics Funding Rounds
Nutcracker Therapeutics raised $60.0M in an undisclosed round announced in Sep 2020.
1.5 years later, a Series C of $167M was announced in Mar 2022.
Nutcracker Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Nutcracker Therapeutics Funding Compared to Other Biotechnology Startups
Nutcracker Therapeutics' latest round of $167M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nutcracker Therapeutics in Biotechnology and Emeryville
Companies Similar to Nutcracker Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Nutcracker Therapeutics Funding FAQs
What does Nutcracker Therapeutics do?
Nutcracker Therapeutics is a biotech company that develops and produces mRNA therapeutics on its proprietary, microfluidic, and biochip-based platform. The company specializes in a fully-integrated system for the production of mRNA-therapeutics at the push of a button that enables scalable on-demand experimental and manufacturing capacity, thereby enabling healthcare companies to produce complex multimodal therapeutics at point of care. Nutcracker Therapeutics combines the productivity of RNA biology with innovations inspired by semiconductor manufacturing techniques to develop a proprietary miniaturized platform that enables the rapid discovery, development, and manufacturing of mRNA therapies and vaccines. Its ACORN platform is a first-of-its-kind, computer-controlled RNA manufacturing system that starts with a nucleic acid sequence of interest and produces optimized nanoparticle-encapsulated RNA therapeutics on dedicated, single-use biochips. Igor Khandros and Benjamin Eldridge established the company in Emeryville, California in 2018.
How much funding has Nutcracker Therapeutics raised?
Nutcracker Therapeutics has raised $227M across 2 rounds on record. The most recent is a Series C of $167M announced in Mar 2022.
When did Nutcracker Therapeutics last raise funding?
Nutcracker Therapeutics' most recent funding round on record is a Series C of $167M, announced in Mar 2022.
Who founded Nutcracker Therapeutics?
FundedIQ lists Benjamin Eldridge (Founder) at Nutcracker Therapeutics.
Who is the CEO of Nutcracker Therapeutics?
Igor Khandros is listed as CEO at Nutcracker Therapeutics.
Where is Nutcracker Therapeutics headquartered?
Nutcracker Therapeutics is based in Emeryville, California, United States.
How many employees does Nutcracker Therapeutics have?
Nutcracker Therapeutics is in the 101-250 employee band.
How does Nutcracker Therapeutics' funding compare to other Biotechnology startups?
Nutcracker Therapeutics' latest round of $167M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nutcracker Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nutcracker Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.